Suzuki, Shigeki
Asakura, Keisuke http://orcid.org/0000-0002-4491-3456
Okui, Masayuki
Sawafuji, Makoto
Shigenobu, Takao
Tajima, Atsushi
Kaseda, Kaoru
Masai, Kyohei
Hishida, Tomoyuki
Asamura, Hisao
Article History
Received: 4 February 2022
Accepted: 12 March 2022
First Online: 28 March 2022
Declarations
:
: KA, KM, KK, TH, and HA received unrestricted institutional funds from Eli Lilly Japan K.K., Shionogi & Co., Ltd., Taiho Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Kyowa Kirin Co., Ltd., and Covidien Japan Inc.